SCHEMBL4609375

SCHEMBL4609375

CNC(=O)C1(N2CCCCC2)CCN(CCC(CNCC(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 9/20 0.51
TACR1 P25103 3/20 0.47
MCHR1 Q99705 4/20 0.46
CCR5 P51681 1/20 0.44
TACR3 P29371 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609449 0.90 TACR2 (0.55) TACR2TACR1MCHR1
SCHEMBL4611535 0.89 TACR2 (0.53) TACR2TACR1
SCHEMBL4609381 0.84 TACR2 (0.75) TACR2TACR1
SCHEMBL14434385 0.84 TACR2 (0.75) TACR2TACR1
SCHEMBL4609840 0.82 TACR2 (0.50) TACR2TACR1
SCHEMBL14434394 0.76 TACR2 (0.51) TACR2TACR1MCHR1
SCHEMBL4609755 0.76 MCHR1 (0.46) TACR2TACR1MCHR1
SCHEMBL14435100 0.74 TACR2 (0.77) TACR2TACR1
SCHEMBL4609451 0.74 TACR2 (0.77) TACR2TACR1
SCHEMBL8828884 0.74 TACR2 (0.69) TACR2TACR1TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979319-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS Solvay Pharmaceuticals GmbH (DE) 2008-10-15 EP disclosed
WO-2007088181-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-08-09 WO disclosed